Clinical Trial Update: Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation. [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of L-arginine and liposomal vitamin C in severe COPD patients undergoing pulmonary rehabilitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Respiratory Failure

Drugs mentioned

• L-Arginine (L-Arginine)
• Liposomal Vitamin C (ascorbic acid liposomal formulation)

Snippet

Sponsor: Istituti Clinici Scientifici Maugeri SpA | Conditions: Chronic Obstructive Pulmonary Disease, Respiratory Failure | NA | Status: COMPLETED